Skip to content

Efficacy of FloSeal in brain tumor resection

Efficacy of FloSeal in brain tumor resection - Efficacy of FloSeal in brain tumor resection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000028579
Enrollment
100
Registered
2017-08-08
Start date
2017-08-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain tumor

Interventions

After tumor removal, we would apply FloSeal at the point of bleeding which was difficult to stop with other methods.

Sponsors

Keio University School of Medicine Department of Neurosurgery
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients will undergo the tumor resection surgery, who is thought to be used FloSeal.

Exclusion criteria

Exclusion criteria: Who has allergy to bovine protein. Who has infection at the surgical field. The tumor is in the eye ball Who has coagulopathy Pregnant patient Who is diagnosed with Hypofibrinogenaemia Who the surgeons thought that it is not appropriate to use FloSeal.

Design outcomes

Primary

MeasureTime frame
Efficacy of FloSeal to stop bleeding The bleeding would be classified in 4 grades. (1.Mild 2. Moderate 3. Sever 4. Life-threatening) Succeed of hemostasis or not would be evaluated after applying FloSeal.

Secondary

MeasureTime frame
Events occurred during patients' hospitalization for the first one week after the surgery.

Countries

Japan

Contacts

Public ContactMasahiro Toda

Keio University School of Medicine Department of Neurosurgery

todam@keio.jp03-5363-3808

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026